Results: 3

1.
Figure 2.

Figure 2. From: Diagnosis and management of primary hyperparathyroidism in Europe.

Preferred management strategies for asymptomatic PHPT. Values (%) are respondents’ answers to the multi-choice Question 12 ‘When a PHPT patient is asymptomatic do you … ?’ aRecommendation based on 2002 NIH Consensus Development Guidelines. 3

B.L. Langdahl, et al. QJM. 2012 June;105(6):519-525.
2.
Figure 1.

Figure 1. From: Diagnosis and management of primary hyperparathyroidism in Europe.

Preferred management strategies for symptomatic PHPT. Values (%) are respondents’ answers to the multi-choice Question 11 ‘When a PHPT patient is symptomatic do you … ?’ Respondents chose a single answer from a multi-choice list.

B.L. Langdahl, et al. QJM. 2012 June;105(6):519-525.
3.
Figure 3.

Figure 3. From: Diagnosis and management of primary hyperparathyroidism in Europe.

Patients receiving preferred combination pharmacological therapies for the treatment of PHPT. Values are estimate percentages of the number of patients with PHPT receiving combination therapy given by those physicians ranking combination therapy from 1–3 (1, most suitable; 6, least suitable).

B.L. Langdahl, et al. QJM. 2012 June;105(6):519-525.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk